Literature DB >> 33941896

Selective multiplexed enrichment for the detection and quantitation of low-fraction DNA variants via low-depth sequencing.

Ping Song1, Sherry X Chen1, Yan Helen Yan1,2, Alessandro Pinto3, Lauren Y Cheng1, Peng Dai1, Abhijit A Patel4, David Yu Zhang5,6.   

Abstract

DNA sequence variants with allele fractions below 1% are difficult to detect and quantify by sequencing owing to intrinsic errors in sequencing-by-synthesis methods. Although molecular-identifier barcodes can detect mutations with a variant-allele frequency (VAF) as low as 0.1% using next-generation sequencing (NGS), sequencing depths of over 25,000× are required, thus hampering the detection of mutations at high sensitivity in patient samples and in most samples used in research. Here we show that low-frequency DNA variants can be detected via low-depth multiplexed NGS after their amplification, by a median of 300-fold, using polymerase chain reaction and rationally designed 'blocker' oligonucleotides that bind to the variants. Using an 80-plex NGS panel and a sequencing depth of 250×, we detected single nucleotide polymorphisms with a VAF of 0.019% and contamination in human cell lines at a VAF as low as 0.07%. With a 16-plex NGS panel covering 145 mutations across 9 genes involved in melanoma, we detected low-VAF mutations (0.2-5%) in 7 out of the 19 samples of freshly frozen tumour biopsies, suggesting that tumour heterogeneity could be notably higher than previously recognized.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33941896     DOI: 10.1038/s41551-021-00713-0

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  45 in total

1.  Detection and quantification of rare mutations with massively parallel sequencing.

Authors:  Isaac Kinde; Jian Wu; Nick Papadopoulos; Kenneth W Kinzler; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-17       Impact factor: 11.205

2.  Detection of ultra-rare mutations by next-generation sequencing.

Authors:  Michael W Schmitt; Scott R Kennedy; Jesse J Salk; Edward J Fox; Joseph B Hiatt; Lawrence A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-01       Impact factor: 11.205

Review 3.  Coming of age: ten years of next-generation sequencing technologies.

Authors:  Sara Goodwin; John D McPherson; W Richard McCombie
Journal:  Nat Rev Genet       Date:  2016-05-17       Impact factor: 53.242

4.  Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.

Authors:  Maria C Schwaederlé; Sandip P Patel; Hatim Husain; Megumi Ikeda; Richard B Lanman; Kimberly C Banks; AmirAli Talasaz; Lyudmila Bazhenova; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2017-05-24       Impact factor: 12.531

Review 5.  The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies.

Authors:  Laurence Zitvogel; Yuting Ma; Didier Raoult; Guido Kroemer; Thomas F Gajewski
Journal:  Science       Date:  2018-03-23       Impact factor: 47.728

6.  Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

Authors:  Cynthia X Ma; Ron Bose; Feng Gao; Rachel A Freedman; Melinda L Telli; Gretchen Kimmick; Eric Winer; Michael Naughton; Matthew P Goetz; Christy Russell; Debu Tripathy; Melody Cobleigh; Andres Forero; Timothy J Pluard; Carey Anders; Polly Ann Niravath; Shana Thomas; Jill Anderson; Caroline Bumb; Kimberly C Banks; Richard B Lanman; Richard Bryce; Alshad S Lalani; John Pfeifer; Daniel F Hayes; Mark Pegram; Kimberly Blackwell; Philippe L Bedard; Hussam Al-Kateb; Matthew J C Ellis
Journal:  Clin Cancer Res       Date:  2017-07-05       Impact factor: 12.531

7.  Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform.

Authors:  Melanie Schirmer; Umer Z Ijaz; Rosalinda D'Amore; Neil Hall; William T Sloan; Christopher Quince
Journal:  Nucleic Acids Res       Date:  2015-01-13       Impact factor: 16.971

8.  Detection and localization of surgically resectable cancers with a multi-analyte blood test.

Authors:  Joshua D Cohen; Lu Li; Yuxuan Wang; Christopher Thoburn; Bahman Afsari; Ludmila Danilova; Christopher Douville; Ammar A Javed; Fay Wong; Austin Mattox; Ralph H Hruban; Christopher L Wolfgang; Michael G Goggins; Marco Dal Molin; Tian-Li Wang; Richard Roden; Alison P Klein; Janine Ptak; Lisa Dobbyn; Joy Schaefer; Natalie Silliman; Maria Popoli; Joshua T Vogelstein; James D Browne; Robert E Schoen; Randall E Brand; Jeanne Tie; Peter Gibbs; Hui-Li Wong; Aaron S Mansfield; Jin Jen; Samir M Hanash; Massimo Falconi; Peter J Allen; Shibin Zhou; Chetan Bettegowda; Luis A Diaz; Cristian Tomasetti; Kenneth W Kinzler; Bert Vogelstein; Anne Marie Lennon; Nickolas Papadopoulos
Journal:  Science       Date:  2018-01-18       Impact factor: 47.728

9.  Integrated digital error suppression for improved detection of circulating tumor DNA.

Authors:  Aaron M Newman; Alexander F Lovejoy; Daniel M Klass; David M Kurtz; Jacob J Chabon; Florian Scherer; Henning Stehr; Chih Long Liu; Scott V Bratman; Carmen Say; Li Zhou; Justin N Carter; Robert B West; George W Sledge; Joseph B Shrager; Billy W Loo; Joel W Neal; Heather A Wakelee; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Biotechnol       Date:  2016-03-28       Impact factor: 54.908

10.  Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.

Authors:  Aaron N Hata; Matthew J Niederst; Hannah L Archibald; Maria Gomez-Caraballo; Faria M Siddiqui; Hillary E Mulvey; Yosef E Maruvka; Fei Ji; Hyo-eun C Bhang; Viveksagar Krishnamurthy Radhakrishna; Giulia Siravegna; Haichuan Hu; Sana Raoof; Elizabeth Lockerman; Anuj Kalsy; Dana Lee; Celina L Keating; David A Ruddy; Leah J Damon; Adam S Crystal; Carlotta Costa; Zofia Piotrowska; Alberto Bardelli; Anthony J Iafrate; Ruslan I Sadreyev; Frank Stegmeier; Gad Getz; Lecia V Sequist; Anthony C Faber; Jeffrey A Engelman
Journal:  Nat Med       Date:  2016-02-01       Impact factor: 53.440

View more
  5 in total

Review 1.  Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.

Authors:  Ping Song; Lucia Ruojia Wu; Yan Helen Yan; Jinny X Zhang; Tianqing Chu; Lawrence N Kwong; Abhijit A Patel; David Yu Zhang
Journal:  Nat Biomed Eng       Date:  2022-01-31       Impact factor: 29.234

2.  Oncogene Concatenated Enriched Amplicon Nanopore Sequencing for rapid, accurate, and affordable somatic mutation detection.

Authors:  Deepak Thirunavukarasu; Lauren Y Cheng; Ping Song; Sherry X Chen; Mitesh J Borad; Lawrence Kwong; Phillip James; Daniel J Turner; David Yu Zhang
Journal:  Genome Biol       Date:  2021-09-06       Impact factor: 13.583

3.  Calibration-free NGS quantitation of mutations below 0.01% VAF.

Authors:  Peng Dai; Lucia Ruojia Wu; Sherry Xi Chen; Michael Xiangjiang Wang; Lauren Yuxuan Cheng; Jinny Xuemeng Zhang; Pengying Hao; Weijie Yao; Jabra Zarka; Ghayas C Issa; Lawrence Kwong; David Yu Zhang
Journal:  Nat Commun       Date:  2021-10-21       Impact factor: 14.919

Review 4.  A narrative review of tumor heterogeneity and challenges to tumor drug therapy.

Authors:  Liang Zhu; Minlin Jiang; Hao Wang; Hui Sun; Jun Zhu; Wencheng Zhao; Qiyu Fang; Jia Yu; Peixin Chen; Shengyu Wu; Zixuan Zheng; Yayi He
Journal:  Ann Transl Med       Date:  2021-08

Review 5.  Cell-free DNA technologies for the analysis of brain cancer.

Authors:  Richard Mair; Florent Mouliere
Journal:  Br J Cancer       Date:  2021-11-22       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.